We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Ascendis Pharma and Novo Nordisk Sign Collaboration for Development and Commercialization of TransCon Technology-based Products in Metabolic and Cardiovascular Diseases - Collaboration leverages...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 6 | 4.6511627907 | 129 | 135 | 129 | 72 | 133.2005571 | DE |
4 | 10 | 8 | 125 | 135 | 124 | 60 | 129.85872576 | DE |
12 | 3 | 2.27272727273 | 132 | 135 | 112 | 71 | 122.49120493 | DE |
26 | 15 | 12.5 | 120 | 135 | 97 | 66 | 122.70444598 | DE |
52 | 3 | 2.27272727273 | 132 | 143 | 97 | 58 | 124.90050095 | DE |
156 | 3 | 2.27272727273 | 132 | 143 | 97 | 58 | 124.90050095 | DE |
260 | 3 | 2.27272727273 | 132 | 143 | 97 | 58 | 124.90050095 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions